Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Structure-based design to explore the anticancer efficacy of organometallic Pt(II)- and Au(III)-N-heterocyclic carbene (NHC) complexes
Pooja
Das
a,
Sraddhya
Roy
b,
Chaitali
Das
a,
Raju
Biswas
c,
Nabanita
Chaterjee
*b and
Joydev
Dinda
*a
aDepartment of Chemistry, Utkal University, Bhubaneswar 751004, Odisha, India. E-mail: joydevdinda@gmail.com
bDepartment of Receptor Biology and Tumor Metastasis, Chittaranjan National Cancer Institute, Kolkata 700026, West Bengal, India
cDepartment of Chemistry, CSIR – Indian Institute of Chemical Biology, Kolkata 700032, West Bengal, India
First published on 3rd March 2025
Abstract
Correction for ‘Structure-based design to explore the anticancer efficacy of organometallic Pt(II)- and Au(III)-N-heterocyclic carbene (NHC) complexes’ by Pooja Das et al., New J. Chem., 2024, 48, 16189–16201, https://doi.org/10.1039/D4NJ02853H.
The original manuscript reported incorrect treatment doses for the MTT assay. The correct values were 1 nM, 10 nM, 100 nM, 1000 nM, and 10
![[thin space (1/6-em)]](https://www.rsc.org/images/entities/char_2009.gif)
000 nM of complexes 2 and 3.
The description of subsequent experiments did not give explicit details of the dose of compound used. A derived IC50 value of 8.4 nM of complex 3 was used for all experiments.
The authors would also like to note that the compounds were prepared as stock solutions in DMSO. The compounds were soluble and stable in DMSO, as confirmed by NMR analysis. The final concentration of the solutions was 0.5% of DMSO.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2025 |